(R)-2-(BOC-AMINO)-2-PHENYLPROPANOIC ACID, 95.0%, 250mg

(2'-Methyl-[1,1'-biphenyl]-4-yl)boronic acid, 95.0%, 1g

4,5,6,7-Tetrahydro-1H-pyrazolo[4,3-c]pyridine, 95.0%, 1g

TERT-BUTYL 7-AMINO-2-AZASPIRO[4.5]DECANE-2-CARBOXYLATE, 95.0%, 500mg

4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)-METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 10g

6-(methoxymethyl)-2-pyridinecarboxylic acid hydrochloride hydrate, 95.0%, 250mg

2-(Trifluoromethoxy)benzylamine>98.0%(GC)(T)5g

2-(5-Bromothiophen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, 95+%, 200mg

N-(4-tert-Butyl-phenyl)-2-chloro-acetamide, 95.0%, 10g

5-Methyl-5-(4-methylphenyl)imidazolidine-2,4-dione, 97%, 100mg

3-(4-(Benzyloxy)-3-methoxyphenyl)propan-1-ol, 95.0%, 1g

Eyewash bottle Actiomedic® BioPhos®74 solution, 1 piece

7-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 95.0%, 5g